Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review

被引：0
作者：
Borella, Fulvio [1 ]
Carosso, Marco [1 ]
Chiparo, Maria Pia [1 ]
Ferraioli, Domenico [2 ]
Bertero, Luca [3 ]
Gallio, Niccolo [4 ]
Preti, Mario [1 ]
Cusato, Jessica [5 ]
Valabrega, Giorgio [6 ]
Revelli, Alberto [4 ]
Marozio, Luca [1 ]
Cosma, Stefano [1 ]
机构：
[1] Univ Turin, Dept Surg Sci, Gynecol & Obstet 1U, I-10126 Turin, Italy
[2] Comprehens Canc Ctr, Dept Gynecol, Leon Berard, F-69008 Lyon, France
[3] Univ Turin, Dept Med Sci, Pathol Unit, I-10126 Turin, Italy
[4] Univ Turin, Dept Surg Sci, Gynecol & Obstet 2U, I-10126 Turin, Italy
[5] Univ Turin, Dept Med Sci, Lab Clin Pharmacol & Pharmacogenet, I-10149 Turin, Italy
[6] Univ Turin, Ordine Mauriziano Hosp, Dept Oncol, Med Oncol, I-10128 Turin, Italy
来源：
PATHOGENS | 2025年 / 14卷 / 02期
关键词：
ovarian cancer; oncolytic virus; virus; adenovirus; herpes simplex virus; vaccinia virus; myxoma virus; vesicular stomatitis virus; HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; CONDITIONALLY-REPLICATIVE ADENOVIRUS; COLONY-STIMULATING FACTOR; YEAST CYTOSINE DEAMINASE; SODIUM-IODIDE SYMPORTER; PHASE-I TRIAL; VACCINIA VIRUS; MEASLES-VIRUS; GENE-TRANSFER;
D O I：
10.3390/pathogens14020140
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Ovarian cancer (OC) remains the most lethal gynecologic malignancy with limited effective treatment options. Oncolytic viruses (OVs) have emerged as a promising therapeutic approach for cancer treatment, capable of selectively infecting and lysing cancer cells while stimulating anti-tumor immune responses. Preclinical studies have demonstrated significant tumor regression and prolonged survival in OC models using various OVs, such as herpes simplex. Early-phase clinical trials have shown a favorable safety profile, though the impact on patient survival has been modest. Current research focuses on combining OVs with other treatments like immune checkpoint inhibitors to enhance their efficacy. We provide a comprehensive overview of the current understanding and future directions for utilizing OVs in the management of OC.
引用
收藏
页数：27
相关论文
共 192 条
  • [61] Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
    Grossardt, Christian
    Engeland, Christine E.
    Bossow, Sascha
    Halama, Niels
    Zaoui, Karim
    Leber, Mathias F.
    Springfeld, Christoph
    Jaeger, Dirk
    von Kalle, Christof
    Ungerechts, Guy
    [J]. HUMAN GENE THERAPY, 2013, 24 (07) : 644 - 654
  • [62] Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
    Gujar, Shashi
    Pol, Jonathan G.
    Kim, Youra
    Lee, Patrick W.
    Kroemer, Guido
    [J]. TRENDS IN IMMUNOLOGY, 2018, 39 (03) : 209 - 221
  • [63] Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
    Hartkopf, A. D.
    Bossow, S.
    Lampe, J.
    Zimmermann, M.
    Taran, F-A
    Wallwiener, D.
    Fehm, T.
    Bitzer, M.
    Lauer, U. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 362 - 368
  • [64] Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy
    Havunen, Riikka
    Siurala, Mikko
    Sorsa, Suvi
    Groenberg-Vaehae-Koskela, Susanna
    Behr, Michael
    Taehtinen, Siri
    Santos, Joao Manuel
    Karell, Pauliina
    Rusanen, Juuso
    Nettelbeck, Dirk M.
    Ehrhardt, Anja
    Kanerva, Anna
    Hemminki, Akseli
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2017, 4 : 77 - 86
  • [65] Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers
    Heinio, Camilla
    Kudling, Tatiana
    Quixabeira, Dafne
    Cervera-Carrascon, Victor
    Havunen, Riikka
    Gronberg-Vaha-Koskela, Susanna
    Santos, Joao Manuel
    Tapper, Johanna
    Kanerva, Anna
    Hemminki, Akseli
    [J]. DISEASES, 2022, 10 (03)
  • [66] TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological Signaling
    Heinio, Camilla
    Havunen, Riikka
    Santos, Joao
    de Lint, Klaas
    Cervera-Carrascon, Victor
    Kanerva, Anna
    Hemminki, Akseli
    [J]. CELLS, 2020, 9 (04)
  • [67] An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
    Heise, C
    Hermiston, T
    Johnson, L
    Brooks, G
    Sampson-Johannes, A
    Williams, A
    Hawkins, L
    Kirn, D
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1134 - 1139
  • [68] Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status
    Heise, C
    Ganly, I
    Kim, YT
    Sampson-Johannes, A
    Brown, R
    Kirn, D
    [J]. GENE THERAPY, 2000, 7 (22) : 1925 - 1929
  • [69] Hirasawa K, 2002, CANCER RES, V62, P1696
  • [70] Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
    Holbrook, Molly C.
    Goad, Dakota W.
    Grdzelishvili, Valery Z.
    [J]. CANCERS, 2021, 13 (05) : 1 - 33
234567891011